Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2023-01-01
2024-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Primary Open-angle Glaucoma on Visual-motor Coordination
NCT06692205
Effect of Peripapillary Atrophy to Diagnose Glaucoma in High Myopia
NCT05964634
Artificial Intelligence-assissted Glaucoma Evaluation
NCT03268031
OCTA in Patients With Primary Open-angle Glaucoma
NCT06214676
Glaucoma Screening Using Dynamic Analysis of Computerized Pupillary Light Reflex Assessment Device
NCT04595227
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case group
Patients with primary open angle glaucoma
C-Read test
C-Read is a reliable and valid clinical tool for quantitatively testing the reading ability of readers of simplified Chinese characters.
Control group
Healthy people
C-Read test
C-Read is a reliable and valid clinical tool for quantitatively testing the reading ability of readers of simplified Chinese characters.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
C-Read test
C-Read is a reliable and valid clinical tool for quantitatively testing the reading ability of readers of simplified Chinese characters.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥18 years old
* with open angles on gonioscopy
* best-corrected visual acuity ≥0.5
* spherical refraction within ±5.0 diopters (D), and/or cylinder correction within 3.0 D
Exclusion Criteria
* eyes with a history of trauma or inflammation
* undergone an intraocular surgery or laser within the previous 6 months/except uncomplicated cataract surgery
* using systemic or topical medications that could affect pupil responses, including pilocarpine or atropine
* presence of any media opacities that prevented good quality OCT or fundus images
* presence of any retinal or neurological disease other than glaucoma
* abnormal ocular motility that prevents binocular fixation (eg, nystagmus, strabismus)
* with severe systemic diseases or psychiatric disorders
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00006761-M2022800
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.